<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1264</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12744898</PubmedId>
            <Abstract>Matix protein 2 (M2) is a transmembrane protein of influenza type A virus. It contains a 23 aa long ectodomain (M2e) that is highly conserved amongst human influenza type A viruses. M2e-specific antibodies have been shown to restrict virus growth in vitro and in vivo and thus have the potential of providing cross-reactive resistance to influenza type A virus infection. We attempted to induce M2e-specific protection with synthetic multiple antigen peptide (MAP) constructs that contained covalently linked M2e- and Th-determinant peptides. Mice, vaccinated twice by the intranasal (i.n.) route with adjuvanted M2e-MAPs exhibited significant resistance to virus replication in all sites of the respiratory tract. Compared to mice primed by two consecutive heterosubtypic infections, resistance was of similar strength in nasal and tracheal tissue but lower in pulmonary tissue. Importantly, the protection in M2e-MAP- and infection-immunized mice appeared to be mediated by distinct immune mechanisms. This suggests that stronger protection may be achievable by combining both protective activities.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>2616-26</ArticlePages>
            <ArticleTitle>Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Mozdzanowska</LastName>
                    <ForeName>Krystyna</ForeName>
                </Author>
                <Author>
                    <LastName>Feng</LastName>
                    <ForeName>JinQi</ForeName>
                </Author>
                <Author>
                    <LastName>Eid</LastName>
                    <ForeName>Mark</ForeName>
                </Author>
                <Author>
                    <LastName>Kragol</LastName>
                    <ForeName>Goran</ForeName>
                </Author>
                <Author>
                    <LastName>Cudic</LastName>
                    <ForeName>Mare</ForeName>
                </Author>
                <Author>
                    <LastName>Otvos</LastName>
                    <ForeName>Laszlo</ForeName>
                    <Suffix>Jr</Suffix>
                </Author>
                <Author>
                    <LastName>Gerhard</LastName>
                    <ForeName>Walter</ForeName>
                </Author>
            </Authors>
            <Affiliations>Immunology Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104-4268, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Influenza Vaccines;M-protein, influenza virus;M2 protein, Influenza A virus;Vaccines, Synthetic;Viral Matrix Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(blood); Antibody Formation; CD4-Positive T-Lymphocytes(immunology); Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunity, Innate(immunology); Influenza A virus(immunology; isolation &amp; purification); Influenza Vaccines(immunology); Lung(virology); Lymphocyte Activation; Mice; Molecular Sequence Data; Nose(virology); Orthomyxoviridae Infections(immunology); Protein Structure, Secondary; Time Factors; Vaccines, Synthetic(immunology); Viral Matrix Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>21</Volume>
                <Issue>19-20</Issue>
                <Title>Vaccine</Title>
                <Issn>0264-410X</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>S1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SFERFEIFPKE</LinearSequence>
                        <StartingPosition>127</StartingPosition>
                        <EndingPosition>137</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8JUU5</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>183764</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57751</EpitopeId>
                <ReferenceStartingPosition>110</ReferenceStartingPosition>
                <ReferenceEndingPosition>120</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>18548</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SFERFEIFPKE</LinearSequence>
                                            <StartingPosition>127</StartingPosition>
                                            <EndingPosition>137</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q8JUU5</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>183764</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>S1</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Cholera toxin</Adjuvant>
                                <Adjuvant>CpG</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>One dose of 50 ul vaccine (3 ug MAP) + adjuvant; Boosters- number and time not specified</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogens used were mannosylated or non-mannosylated multi-epitope constructs consisting of 1-4 copies of M2e (a matrix protein 2 ectodomain epitope from influenza A virus), 1 copy each of this epitope and S2 (a second hemagglutinin peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>Lymph node cells</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>116</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>S1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SFERFEIFPKE</LinearSequence>
                                        <StartingPosition>127</StartingPosition>
                                        <EndingPosition>137</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8JUU5</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific clones also proliferated in response to the epitope and in response to multiple antigenic peptide constructs containing this epitope, a second hemagglutinin peptide (S2), and one or more copies of a matrix protein 2 ectodomain epitope from influenza A virus (M2e).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>18517</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Immunization and generation of Th clones is is described in J. Virol. 1991; 65:364-372.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>10000000</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>116</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>hemagglutinin HA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>Q8JUU5</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific clones proliferated in response to HA.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>S2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HNTNGVTAACSHE</LinearSequence>
                        <StartingPosition>143</StartingPosition>
                        <EndingPosition>155</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8JUU5</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>183764</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>24408</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>18528</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Immunization and generation of Th clones is is described in  J. Virol. 1991; 65:364-372.  Immunization and generation of Th clones is is described in  J. Virol. 1991; 65:364-372.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>10000000</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>183</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>hemagglutinin HA</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>Q8JUU5</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>5.1-5R6 T-cell clones (S2-specific) were used in the proliferation assay. The assay antigen was used at 0.5-500 nM with maximum proliferation occuring at 50 nM.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>18524</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Immunization and generation of Th clones is is described in  J. Virol. 1991; 65:364-372.  Immunization and generation of Th clones is is described in  J. Virol. 1991; 65:364-372.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>10000000</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>183</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>S2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HNTNGVTAACSHE</LinearSequence>
                                        <StartingPosition>143</StartingPosition>
                                        <EndingPosition>155</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8JUU5</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>5.1-5R6 T-cell clones (S2-specific) were used in the proliferation assay. The assay antigen was used at 0.5-500 nM with maximum proliferation occuring at 5 nM.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M2e</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSDP</LinearSequence>
                        <StartingPosition>2</StartingPosition>
                        <EndingPosition>25</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35938.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>183764</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>59319</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>S residues were substituted for the natural C residues at positions 16 and 18 to prevent disulfide bonding. The paper uses the A/PR/8/34/Mount Sinai strain, but the sequence of the M2e peptide is not found in this strain. The Swiss Prot ID given is for Influenza A virus (A/USSR/90/77(H1N1). Several flu strains contain this sequence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <BCellId>20335</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P35938.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>183764</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Matrix protein 2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The authors specify that mAb 14C2 is specific to this epitope. Multi-epitope constructs consisting of 1 copy of M2e (a matrix protein 2 ectodomain epitope from influenza A virus), 1 copy each of S1 and S2 (hemagglutinin peptides) were used as antigens.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>14C2</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSDP</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35938.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>20267</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLLTEVETPIRNEWGCRCNDSSDP</LinearSequence>
                                            <StartingPosition>2</StartingPosition>
                                            <EndingPosition>25</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35938.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>183764</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2e</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Cholera toxin</Adjuvant>
                                <Adjuvant>CpG</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>One dose of 50 ul vaccine (3 ug MAP)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen used was a multi-epitope construct consisting of 4 copies of an analog of M2e (SLLTEVETPIRNEWGCRSNDSSDP), 1 copy each of S1 and S2 (hemagglutinin peptides). MedLN cells gathered 10-40 days after booster.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymph Node</CellTissueType>
                            <CellType>Lymph node cells</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>627</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M2e</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSDP</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35938.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>183764</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

